与CYP2D6阿片类药物一起使用CYP2D6抑制剂:与治疗疼痛的急诊室访问的关联
Noor Ahmed Nahid1, Caitrin W McDonough1, Yu-Jung Jenny Wei2
1Department of Pharmacotherapy and Translational Research and Center for Pharmacogenomics and Precision Medicine, University of Florida College of Pharmacy, Gainesville, Florida, USA.
Clinical pharmacology and therapeutics
|May 27, 2024
概括
患者服用CYP2D6抑制剂抗抑郁药与可,特拉马多尔,可代因或氧可一起,经历了更多与疼痛相关的急诊室访问. 这表明,由于阿片类药物激活减少,疼痛控制可能存在问题.
科学领域:
- 药理学 药理学是指药理学的学科.
- 临床药房 临床药房
- 疼痛管理 疼痛管理
背景情况:
- 细胞染色体P450 2D6 (CYP2D6) 对于激活通常处方的阿片类药物如可,特拉马多尔,可丁和氧可至关重要.
- 经常在抗抑郁药中发现的CYP2D6抑制剂可以降低CYP2D6的活性,导致活性阿片类代谢物的水平降低,并可能降低疼痛缓解.
研究的目的:
- 调查CYP2D6依赖性阿片类药物和CYP2D6抑制剂抗抑郁药的同时使用之间的关联.
- 为了确定这种药物组合是否会增加与疼痛相关问题的急诊室 (ED) 访问.
主要方法:
- 一项回顾性队列研究分析了佛罗里达大学健康 (2015-2021) 的电子健康记录.
- 开始服用可/特拉马多尔/可代因或氧可的成年患者根据同时使用CYP2D6抑制剂抗抑郁药和非抑制剂抗抑郁药进行了分类.
- 使用多变量逻辑回归来评估CYP2D6抑制剂暴露与ED疼痛访问之间的关联.
主要成果:
- 与CYP2D6抑制剂抗抑郁药一起服用可/特拉马多尔/可代因的患者显示,与疼痛相关的ED访问率更高 (3.28%对1.87%,aOR=1.75).
- 同样,服用CYP2D6抑制剂抗抑郁药的氧化使用者有更多与疼痛相关的ED访问 (5.02%对比3.37%,aOR=1.70).
- 这些关联在二次和灵敏度分析中仍然显著.
结论:
- 与CYP2D6抑制剂抗抑郁药同时使用可/特拉马多尔/可丁或氧可与增加了因疼痛而访问急诊室的情况有关.
- 这表明,CYP2D6抑制剂可能导致使用这些特定阿片类药物的患者的疼痛控制不充分.
- 对可能影响阿片类药物疗效的药物相互作用给予临床关注是有必要的.
更多相关视频
相关概念视频
Opioid Analgesics: Synthetic and Semisynthetic Opioids
279
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
279
Opioid Analgesics: Morphine and Other Natural Cogeners
239
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
239
Analgesia and Pain Management
582
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
582
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents
193
Diarrhea, a condition marked by frequent loose or watery bowel movements, can be triggered by multiple factors such as viral or bacterial infections, food intolerances, anxiety, medications, and digestive disorders. Symptoms may include abdominal pain, bloating, nausea, and cramping. Severe or prolonged diarrhea can lead to complications like electrolyte imbalances, malnutrition, and dehydration if left untreated.
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
193
Opioid Receptors: Overview
739
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
739
Combined Effects of Drugs: Synergism
3.9K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.9K


